Wegovy, Ozempic, and Mounjaro are weight loss and diabetes drugs that have made quite a splash in health news. They target regulatory pathways involved in both obesity and diabetes and are widely considered breakthroughs for weight loss and blood sugar control.
But do these drugs point toward a root cause of metabolic disease? What inspired their development in the first place?
